Publication Cover
Amyloid
The Journal of Protein Folding Disorders
Volume 17, 2010 - Issue 3-4
133
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Transthyretin-related vitreous amyloidosis in different endemic areas

, , , , &
Pages 105-108 | Published online: 16 Nov 2010

References

  • Araki S. Type I familial amyloidotic polyneuropathy (Japanese type). Brain Dev 1984;6:128–133.
  • Ando Y, Nakamura M, Araki S. Transthyretin-related familial amyloidotic polyneuropathy. Arch Neurol 2005;62:1057–1062.
  • Sandgren O. Ocular amyloidosis, with special reference to the hereditary forms with vitreous involvement. Surv Ophthalmol 1995;40:173–196.
  • Koga T, Ando E, Hirata A, Fukushima M, Kumura A, Ando Y, Negi A, Tanihara H. Vitreous opacities and outcome of vitreous surgery in patients with familial amyloidotic polyneuropathy. Am J Ophthalmol 2003;135:188–193.
  • Kawaji T, Ando Y, Ando E, Nakamura M, Hirata A, Tanihra H. A case of vitreous amyloidosis without systemic symptoms in familial amyloidotic polyneuropathy. Amyloid 2004;11:257–259.
  • Holmgren G, Hellman U, Lundgren HE, Sandgren O, Suhr OB. Impact of homozygosity for an amyloidogenic transthyretin mutation on phenotype and long term outcome. J Med Genet 2005;42:953–956.
  • Ando E, Ando Y, Okamura R, Uchino M, Ando M, Negi A. Ocular manifestations of familial amyloidotic polyneuropathy type I: long-term follow up. Br J Ophthalmol 1997;81:295–298.
  • Sousa A, Andersson R, Drugge U, Holmgren G, Sandgren O. Familial amyloidotic polyneuropathy in Sweden: geographical distribution, age of onset, and prevalence. Hum Hered 1993;43:288–294.
  • Coelho T, Chorao R, Sousa A, Alves IL, Torres MF, Saraiva MJ. Compound heterozygotes of transthyretin Met30 and transthyretin Met119 are protected from the devastating effects of familial amyloid polyneuropathy. Neuromuscul Disord (suppl) 1996;6:S20.
  • Hammarström P, Schneider F, Kelly JW. Trans-suppression of misfolding in an amyloid disease. Science 2001;293:2459–2462.
  • Snow AD, Wight TN. Proteoglycans in the pathogenesis of Alzheimer's disease and other amyloidoses. Neurobiol Aging 1989;10:481–497.
  • McLaurin J, Yang D, Yip CM, Fraser PE. Review: modulating factors in amyloid-β fibril formation. J Struct Biol 2000;130:259–270.
  • Balazs EA, Denlinger JL. Aging changes in the vitreous. In: Sekuler R, Kline D, Dismukes N, editors. Aging and human visual function. Alan R Liss: New York; 1982. pp 45–57.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.